SCHEMBL4798484

SCHEMBL4798484

CCOC(=O)COc1ccc(C2CCC(N(Cc3ccccc3)C(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
MAPT P10636 2/20 0.46
HSD11B1 P28845 1/20 0.42
KDM4E B2RXH2 2/20 0.41
TRPM8 Q7Z2W7 2/20 0.41
ALOX15 P16050 1/20 0.41
RAB9A P51151 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
OPRM1 P35372 1/20 0.38
NPC1 O15118 1/20 0.38
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4798488 1.00 ALDH1A1 (0.46) ALDH1A1MAPTHSD11B1KDM4ETRPM8
SCHEMBL6276845 0.89 HSD11B1 (0.45) ALDH1A1HSD11B1KDM4EALOX15RAB9A
SCHEMBL5265047 0.82 HSD11B1 (0.48) HSD11B1RAB9ASMN1; SMN2MRGPRX4OPRM1
SCHEMBL4801241 0.82 HSD11B1 (0.48) HSD11B1OPRM1
SCHEMBL4801250 0.82 HSD11B1 (0.48) HSD11B1OPRM1
SCHEMBL5265045 0.81 HSD11B1 (0.44) HSD11B1MRGPRX4OPRM1
SCHEMBL5315344 0.81 HSD11B1 (0.46) HSD11B1OPRM1
SCHEMBL4798444 0.80 HSD11B1 (0.44) HSD11B1OPRM1
SCHEMBL4798450 0.80 HSD11B1 (0.44) HSD11B1OPRM1
SCHEMBL5142020 0.80 ADRB3 (0.46) ALDH1A1MAPTHSD11B1TRPM8ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7453010-B2 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof SANOFI AVENTIS (FR) 2008-11-18 US disclosed
US-20060100283-A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof SANOFI-AVENTIS (FR) 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100283-A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof CHRM1, CHRM2, C1R ALDH1A1 1769/4885MAPT 3646/4885HSD11B1 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.